Filing Flows

Filing Flows › Companies › GeneDx Holdings › Timeline

GeneDx Holdings stock timeline

A year of the price with every insider trade, planned sale, earnings report and material 8-K marked

252 sessions−55.0% to $62.37

GeneDx Holdings (WGS) stock fell 55% over the last 252 sessions, to $62.37. On the way it reported 3 quarters, its insiders filed 23 open-market trades and 2 Form 144 notices of planned sales, and the company filed 2 material 8-Ks. Each is marked on the price and listed with what the stock did next.

WGS: a year of the stock with every disclosure on itWGS: a year of the stock with every disclosure on it$62.41$101$139$178●2026-02-23 · Earnings: beat the EPS estimate by 16.7%◆2026-03-02 · Material definitive agreement▼2026-04-29 · Feeley Kevin sold $26K▼2026-04-29 · Stueland Katherine sold $142K●2026-05-04 · Earnings: missed the EPS estimate by -1407.8%▲2026-05-07 · Meister Keith A. bought $20.2M▲2026-05-08 · Meister Keith A. bought $7.0M▲2026-05-11 · Meister Keith A. bought $19.6M▲2026-05-13 · Meister Keith A. bought $6.4M▲2026-05-14 · Meister Keith A. bought $5.5M▲2026-05-15 · Meister Keith A. bought $1.8M▲2026-05-18 · Casdin Partners Master Fund, L.P. bought $7.4M▲2026-05-19 · Casdin Partners Master Fund, L.P. bought $7.9M▲2026-05-20 · Casdin Partners Master Fund, L.P. bought $6.1M▼2026-06-01 · Feeley Kevin sold $19K▲2026-06-04 · Casdin Eli bought $8.5M▲2026-06-05 · Casdin Eli bought $2.6M▼2026-06-09 · Feeley Kevin sold $68K▼2026-06-09 · Stueland Katherine sold $196K▼2026-06-16 · Feeley Kevin sold $227K▼2026-06-16 · Stueland Katherine sold $638K◆2026-06-16 · Directors and officers: departures, appointments, pay●2026-08-03 · Earnings: beat the EPS estimate by 105.3%▼2026-09-01 · Feeley Kevin sold $31K▽2026-09-01 · Form 144: Kevin Feeley plans to sell $458K▼2026-09-09 · Feeley Kevin sold $108K▼2026-09-09 · Stueland Katherine sold $311K▽2026-09-09 · Form 144: Katherine Stueland plans to sell $1.2M▼2026-09-16 · Feeley Kevin sold $364K▼2026-09-16 · Stueland Katherine sold $1.0M●Earnings report◆8-K event▼Insider sale▲Insider buy▽Planned sale (Form 144)2025-11-062026-11-06
Daily closes, Nov 6, 2025 to Nov 6, 2026; hover a mark for the filing.

Each mark, and what followed

DateKindWhatNext session5 sessions21 sessions
Sep 16, 2026Insider saleStueland Katherine sold $1.0M+2.9% (+3.3% vs SPY)−4.1% (−6.5% vs SPY)−32.1% (−34.0% vs SPY)
Sep 16, 2026Insider saleFeeley Kevin sold $364K+2.9% (+3.3% vs SPY)−4.1% (−6.5% vs SPY)−32.1% (−34.0% vs SPY)
Sep 9, 2026Form 144Form 144: Katherine Stueland plans to sell $1.2M+0.7% (+1.2% vs SPY)+9.7% (+10.9% vs SPY)−22.5% (−24.2% vs SPY)
Sep 9, 2026Insider saleStueland Katherine sold $311K+0.7% (+1.2% vs SPY)+9.7% (+10.9% vs SPY)−22.5% (−24.2% vs SPY)
Sep 9, 2026Insider saleFeeley Kevin sold $108K+0.7% (+1.2% vs SPY)+9.7% (+10.9% vs SPY)−22.5% (−24.2% vs SPY)
Sep 1, 2026Form 144Form 144: Kevin Feeley plans to sell $458K0.0% (+0.7% vs SPY)+1.2% (+1.4% vs SPY)−15.9% (−15.6% vs SPY)
Sep 1, 2026Insider saleFeeley Kevin sold $31K0.0% (+0.7% vs SPY)+1.2% (+1.4% vs SPY)−15.9% (−15.6% vs SPY)
Aug 3, 2026EarningsEarnings: beat the EPS estimate by 105.3%+4.1% (+2.7% vs SPY)+16.9% (+13.4% vs SPY)+26.4% (+23.8% vs SPY)
Jun 16, 20268-KDirectors and officers: departures, appointments, pay−1.2% (−0.6% vs SPY)−5.4% (−2.8% vs SPY)+0.6% (+0.9% vs SPY)
Jun 16, 2026Insider saleStueland Katherine sold $638K−1.2% (−0.6% vs SPY)−5.4% (−2.8% vs SPY)+0.6% (+0.9% vs SPY)
Jun 16, 2026Insider saleFeeley Kevin sold $227K−1.2% (−0.6% vs SPY)−5.4% (−2.8% vs SPY)+0.6% (+0.9% vs SPY)
Jun 9, 2026Insider saleStueland Katherine sold $196K+8.4% (+8.7% vs SPY)+16.9% (+14.8% vs SPY)+29.2% (+27.3% vs SPY)
Jun 9, 2026Insider saleFeeley Kevin sold $68K+8.4% (+8.7% vs SPY)+16.9% (+14.8% vs SPY)+29.2% (+27.3% vs SPY)
Jun 5, 2026Insider buyCasdin Eli bought $2.6M−7.5% (−4.9% vs SPY)+8.1% (+10.6% vs SPY)+15.0% (+16.0% vs SPY)
Jun 4, 2026Insider buyCasdin Eli bought $8.5M+6.0% (+5.6% vs SPY)+2.4% (+6.3% vs SPY)+26.2% (+26.3% vs SPY)
Jun 1, 2026Insider saleFeeley Kevin sold $19K0.0% (−0.2% vs SPY)+0.4% (+2.9% vs SPY)+27.8% (+28.8% vs SPY)
May 20, 2026Insider buyCasdin Partners Master Fund, L.P. bought $6.1M+6.0% (+5.0% vs SPY)+13.5% (+11.2% vs SPY)+33.7% (+31.7% vs SPY)
May 19, 2026Insider buyCasdin Partners Master Fund, L.P. bought $7.9M−1.3% (−0.6% vs SPY)+14.7% (+13.1% vs SPY)+27.9% (+27.6% vs SPY)
May 18, 2026Insider buyCasdin Partners Master Fund, L.P. bought $7.4M+4.6% (+4.7% vs SPY)+14.9% (+14.1% vs SPY)+39.7% (+38.2% vs SPY)
May 15, 2026Insider buyMeister Keith A. bought $1.8M+4.8% (+6.0% vs SPY)+19.7% (+20.5% vs SPY)+45.6% (+44.7% vs SPY)
May 14, 2026Insider buyMeister Keith A. bought $5.5M−0.2% (−1.0% vs SPY)+13.9% (+14.0% vs SPY)+43.1% (+43.1% vs SPY)
May 13, 2026Insider buyMeister Keith A. bought $6.4M−1.4% (−2.0% vs SPY)+6.5% (+7.1% vs SPY)+43.5% (+43.5% vs SPY)
May 11, 2026Insider buyMeister Keith A. bought $19.6M−2.9% (−3.1% vs SPY)−0.1% (−0.3% vs SPY)+32.3% (+32.4% vs SPY)
May 8, 2026Insider buyMeister Keith A. bought $7.0M+0.7% (−0.2% vs SPY)−4.2% (−6.4% vs SPY)+24.6% (+23.5% vs SPY)
May 7, 2026Insider buyMeister Keith A. bought $20.2M+15.4% (+15.7% vs SPY)+11.5% (+10.4% vs SPY)+40.8% (+40.3% vs SPY)
May 4, 2026EarningsEarnings: missed the EPS estimate by -1407.8%+3.8% (+4.2% vs SPY)−47.2% (−49.5% vs SPY)−20.7% (−26.0% vs SPY)
Apr 29, 2026Insider saleStueland Katherine sold $142K−4.9% (−4.9% vs SPY)−65.0% (−66.6% vs SPY)−27.6% (−33.4% vs SPY)
Apr 29, 2026Insider saleFeeley Kevin sold $26K−4.9% (−4.9% vs SPY)−65.0% (−66.6% vs SPY)−27.6% (−33.4% vs SPY)
Mar 2, 20268-KMaterial definitive agreement−7.2% (−7.2% vs SPY)+10.0% (+12.0% vs SPY)−29.1% (−21.1% vs SPY)
Feb 23, 2026EarningsEarnings: beat the EPS estimate by 16.7%+5.9% (+7.0% vs SPY)−2.9% (−2.4% vs SPY)−12.9% (−8.1% vs SPY)

Insiders’ record here

In the year on the chart, GeneDx Holdings' insiders reported 11 open-market buys ($93.1M) and 12 sales ($3.2M). Of the 18 old enough to score, 11 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was +84.6% and after a sale +50.1%.

Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →

What this kind of 8-K usually did

Item8-KsNext session, medianUp next session21 sessions, medianTypical size
1.01 Material definitive agreement23,5250.0%51%+1.0%±1.4%
1.02 Termination of a material agreement2,3680.0%51%+1.1%±1.5%
2.03 New debt or off-balance-sheet obligation13,2680.0%50%+1.2%±1.3%
5.02 Directors and officers: departures, appointments, pay39,174−0.1%48%+0.7%±1.4%

Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →

Report card: every quarter against the estimate → GeneDx Holdings: every quarter → Live insider trades →

Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.